Nymox States Medication for Bigger Prostate Doesn’t Meet Targets Today – 17:32 GMT (Updates shares 4th paragraph.) Nov. 3 (Bloomberg)– Nymox Pharmaceutical Corp. said researches for its drug to address prostate augmentation really did not generate desired results. The shares dove as long as 89 percent. Two stage 3 research
[...] Read More
No comments:
Post a Comment